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Abstract 
 
According to the human capital theory, health is a determinant of the economic development and 
should play a role in the fight against poverty. On the other side, the economic growth, by supplying 
better sanitation, water quality and hygiene, better education and income, may improve population’s 
health. Economists, in investigating the relations between development and health, asked for valid and 
relevant health status measurement. But, on the other hand, the health concept is complex as health 
includes several dimensions, and researchers face a battery of health indicators.  
 
The purpose of this study is to discuss, specifically for economic research, the particularity of each 
health indicator, the potential bias of their measurement, their advantages, disadvantages, and interest. 
As health indicators are too numerous, a selection was done and the analysis concerns the most 
frequent indicators, but also those which should be more used into the economic research perspective. 
Discussed health indicators are life expectancy and healthy life expectancy at birth, mortality rates 
(maternal and infant mortality included), cause-specific morbidity rates, Dalys and Qalys.  
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I – Introduction 
It is now well-admitted that health plays a role in the fight against poverty. The theory of 
human capital told us that not only the quantitative aspect of labour, but also his qualitative aspect 
(such as education and health) matter in the process of economic growth. After a decline of interest on 
this topic in the seventies, we actually assist to a re-emergence of studies focusing on the links 
between health, welfare, and development. The debate in the literature is lively, and some authors 
consider that communicable diseases had contributed to slow down the economic development of 
developing countries (Gallup and Sachs, 2001; Bell, Devarajan and Gerbasch, 2003; Sachs, 2003). In 
2001, the Commission on Macroeconomics and Health (WHO, 2001) concluded in its report that 
“diseases are a barrier to economic growth and that countries have to invest in health”. The importance 
of health in the development was again underlined by the UN member states when they signed in 2000 
the United Nation Millennium Declaration. Among the eight development goals, three relate directly 
to health2.  
Beyond the role of health in the economic development, as written in the report of the 
Commission on Social Determinants of Health: “the development of a society can be judged by the 
quality of its population’s health” (WHO, 2008). Children born today in the world cannot expect to 
live an equal number of years (80 years in developed countries, less than 45 years in some African 
countries). If some countries have improved their population’s health, we know that many countries 
will not achieve the health-related Millennium Development Goals (MDGs). The economic 
development is not the unique cause of this difference as health inequalities are also observed within 
countries. For the macroeconomic commission (WHO, 2001), a large part of deaths in the low-income 
countries should be avoidable while many of the non communicable diseases can be addressed by 
relatively low-cost interventions, especially using preventative actions. For the commission on social 
determinants of health (WHO, 2008), health inequalities can be avoidable by a new approach of 
development. They consider that health and health equity should be the result of social policies further 
that their aim, and that policies and programmes must embrace all the key sectors of society instead.  
                                                 
2
 Child mortality, maternal health, and HIV, Malaria and other diseases 
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Investing in health has at least two justifications, one is economic and one is ethical or moral. Health, 
and more precisely poor health, has a cost. The cost is first a financial or direct cost, bound up with 
curative care. While developing countries, specifically Africa countries, did not start their health 
transition, non communicable diseases such as diabetes, cancers, heart diseases begin to bear in the 
disease burden. Direct cost should then drastically increase. The cost is then indirect or economic 
when a decrease in labour productivity occurs as a consequence of illness. By avoiding cases and 
deaths, health programmes should contribute to decrease direct and indirect costs. Second, improving 
population’s health status and fighting health inequality is in so far ethical as many causes of deaths 
are avoidable without high-cost interventions.  
The health notion is complex as health includes several dimensions. With the progress of the 
medicine, the definition of health has changed over time. From the absence of disease or infirmity, the 
WHO's definition of health became “a state of complete physical, mental and social well-being”. This 
definition relates not only to the promotion of well-being, but also implies that people should have 
access to the treatment and that people affected by physical, mental and social disorders should be 
rehabilitated. Its also implies to obtain indicators which can measure those different aspects of health.  
As we will see, the measurement of health is not simple and health indicators are numerous.  
Before presenting and discussing issues and challenges of health measurement, it is important 
to ask for the objectives of this measurement. The question will be: why or for which objective do we 
need to measuring health? The answer will determine the choice of the health indicator.  
Issues and challenges of measurement of health matter with the objectives of the research. We 
distinguish several types of objectives or perspectives. They would concern:   
i) Public health. In this perspective, it will be essential to assess the level of population’s health 
status, to compare its level and its trend over the time within a specific country or between 
different countries. The definition of health would be sufficiently large, but homogenous, in 
order to make national or international comparisons. The health public perspective could also 
have to identify health priorities or rapidly detect epidemics. As previously, the question will 
be to choose the adequate health indicator; 
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ii) The monitoring progress towards the health MDGs. The need to use alternative indicators 
could be asked for (AbouZahr and Warlaw, 2001; Murray, 2007); 
iii) The assessment of the effects of economic programmes on health. The intensification of the 
agriculture (by intensive use of fertilizers or irrigation), or the dramatically increase of the 
pollution due to fast growth could constitute high health risk factors (Hunter et al., 1993; 
Schirnding, 2002 ; Evans et Smith 2005); 
iv) The economic research in relation with health questions. If we consider that poor health would 
have a negative effect on growth and economic development (Sachs, 2003; Audibert, 2008), 
or low income and economic inequality3 would have an effect on health (Deaton, 2003), we 
are concerned with valid and relevant health status measurement; 
v) The ethical consideration. Beyond the economic aspect of health inequalities (see above), the 
reduction of this inequality matters to the ethic for at least two reasons. As the commission on 
social determinants of health wrote, whether a child can growth and develop to its full 
potential (WHO, 2008) should be the result of social and economic policies. Secondly, the 
importance of early child development on future well-being and economic gains is sufficiently 
shown (Mwabu, 2009).  
But improving health and health equity, identifying health priorities or providing economic 
arguments to health policy makers, need to correctly measure health. Following the WHO’s definition 
of health, those concerned with health status measurement have to know whether they consider the 
only biologic element and refer to biomedical science, or whether they consider the individuals or 
groups’ capacity to live physically, mentally and socially (Breslow, 1989).  
 
II – Health status measurement 
As the consequence of progress in medicine, increases of life expectancy and living standard, 
the idea of health status has changed since the first WHO’s definition of health. The willingness to 
take into consideration not only the disease, but also the consequences of the disease on well-being 
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 By assessing the effect of income inequality on health, researchers help to determine whether and by how much 
income redistribution can improve population (Deaton, 2003). 
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and quality of life allowed to enlarging this idea. The health of individuals includes several 
dimensions. Consequently, the health measurement is not simple and is based on several indicators 
more or less complex. This measure can take several forms or approaches (Breslow, 1989; Starfield, 
1992; Or, 2000; Perronnin, Rochaix and Tubeuf, 2006). The first is objective and based on medical 
examination allowing to detect physiological or psychological anomalies, and to assess general 
physical fitness. The second is functional and consists of determining competence for social 
functioning (one’s ability to eat, walk or bathe without assistance, Katz et al., 1963; Fanshel and Bush, 
1970; Breslow, 1989). Self-completed questionnaire or observations are used to determining that 
competence. The third approach is entirely subjective as individuals, questioned on their self-
perception of health, have to determine their health status by using a graduate scale, for example.  
Either in a perspective of public health, health research, or economic health research, the 
worldwide health community faces a battery of health indicators. A lot are recommended but few 
measured well (Murray, 2007). Improving health measurement and measuring accurately its complex 
dimensions are the next challenge4 as it can serve the purpose of improving the quality of decision 
making (Murray and Frenk, 2008) and the quality of economic evaluation of health. Health statistics 
are necessary inputs in this purpose and that question was already asked in 1992 by Starfield when he 
underlined the lack of information on chronic illness in routinely collected data.  
Due to the complex dimensions of health, instead of using a unique measure of health, we 
dispose of some thousands indicators. Some concern one dimension or one specific disease, some 
includes two or more dimensions. As, it is not possible to present all the available health indicators 
and as is beyond the purpose of this discussion, I decided to follow the standard classification of health 
status indicators, and discuss of methodological issues for some of them.  
Health indicators could be classified into single measures, summary measures and multidimensional 
instruments. 
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a) Single measures of health status 
Indicators in this group fall into four categories: life expectancy (LE); mortality; morbidity and 
nutritional status. Defined and proposed by demographers (LE, mortality indicators) and the medical 
profession, they are considered as objective, precise, with no ambiguousness and for some on them 
(mortality and morbidity indicators), immediately available. But, due to methods of data collection, 
they suffer for important biases, making difficult international comparisons, or the monitoring for 
reaching the MDG targets (see for example Table 1 which gives an idea of diverging results issued 
from different sources). They also are criticized as they only capture one dimension of health 
outcomes, either fatal, underlying the rule of rescue (LE; mortality indicators), either non-fatal 
(morbidity indicators).  
If those indicators are used by demographers, health professionals or epidemiologists in a 
demographic or health public perspective, they also are used by economists when they have to 
determine both the direct and indirect economic cost of health. Several inconvenient can be found for 
health economic research. First, health economists do not contribute or in a small way, to the 
definition and the calculation of health indicators. Now, the preoccupation of health public and 
economic researches is different and the relevance of indicators may not be the same, as we will see 
below. Second, when they use health indicators in order to assess the socioeconomic determinants of 
health, economists, more commonly use, instead of epidemiological models5, econometrics models 
which may not fit well with trend of health or diseases occurrence. Now is the time to accelerate a 
more narrow collaboration between epidemiologists and economists. 
Life expectancy at birth  
Life expectancy at birth is a good indicator of the development level, and partly for that reason, 
this indicator is unsatisfactory for economic research. Due to its high level, life expectancy at birth in 
developed countries began an inadequate indicator for measuring health status, nor the eventual 
consequence of social and economic policy on health. The high increase of the length of life in 
developed countries allowed researchers to questioning its interest if people live their last life years in 
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 For some specific diseases, such as AIDS for example, economists used also epidemiological models. 
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poor health. An indicator (HALE) which would take into account the number of unhealthy life years a 
person could expect to living, has then been built (see section 1.2). 
As it is only available at countries level, this indicator is used into macro-level analyses. But, due 
to its high correlation with economic level, the use of this indicator (such as child mortality6) into 
international comparison, for showing that poor health is a blocking factor for the economic 
development, may be low realist. Using this indicator into economic analysis allowed to assuming that 
health status is a consequence of the economic development and not the reverse.  
Mortality rates 
Numerous indicators of mortality are available, either in theory as in practice. They may be 
classified into gross mortality rates, mortality rates per sex, age, cause and risk factor. In developed 
countries, mortality indicators are well registered and are easily available. It is not the case for a great 
part of developing countries, as death registration systems are poor (Mathers et al. 2005). Boerma et 
al. (2002) estimate that since 1990, “74% of 152 low-income and middle-income countries had no 
data, and another 16% were judged to have poor-quality data”. With the need to monitor progresses 
towards the health MDGs, the publication of country mortality statistics has increased since the 2000 
years. Now, due to the failure of good death registration systems, figures are based on predictions 
rather than direct measures A great effort was done by WHO and UNICEF for improving data quality 
by promoting more homogeneous methods of data collection and using all the available information. 
But as showed in Table 1, for the example of under-five mortality, data are not yet perfectly adjusted. 
This situation may ask questions when one would not only check the progress in achieving MDGs, but 
also assess the effect of health interventions both at macro and micro-level, on mortality. 
It is difficult to measure accurately the levels of mortality. Death registration suffers from two 
biases. First, all deaths might not be recorded, as routine recording is not complete. Second, causes of 
the death, whether it is due to specific disease or to pregnancy may not have been known. In the lack 
of adequate or complete death registration system, identification of mortality rates relies on household 
surveys. The difficulty of getting relatively coherent estimations is underlined in the literature and 
                                                 
6
 The correlation coefficient, R, computing on a panel of 90 countries over the period 1975-2000, between life 
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explains that a lot of studies focused on methods for improving the measure of mortality through 
surveys and interviews. This literature is more abundant for maternal and child mortality. 
Maternal mortality 
The WHO defines the maternal death as “the death of a woman while pregnant or within 42 
days of termination of pregnancy, irrespective of the duration and site of the pregnancy, for any cause 
relative to or aggravated by the pregnancy or its management, but not for accidental or incidental 
causes” (WHO, 2007). Three statistical measures are available. The maternal mortality ratio (MMR), 
the maternal mortality rate (MMRate) and the adult of lifetime risk of maternal death7. 
Several methods are used for estimating the level of maternal mortality. Each of these methods 
has limitations, gives different estimations and has uncertainty wide margins. For those reasons, it 
would be wrong to interpret small numerical differences in countries or between periods, as 
representing real differences (WHO, 2007). These methods and their limitations are well discussed in 
the recent literature (see among others authors, Hill, Abou Zarh, Wardlaw, 2001; Smith et al. 2001; 
Bobak et al. 2002; Boerma et al. 2007; Fauveau, 2006, and also the WHO special bulletin, of 2006, n° 
84, and the document on maternal mortality published by the WHO in 2007). We shortly presented 
here a summary of those methods and their limitations.  
One method is based on household surveys which identify pregnancy-related deaths, but not 
maternal deaths as those deaths are rare events that require large sample sizes to have the probability 
to correctly observe this event. In order to copy with this necessity, the sisterhood method has been 
proposed. Information on women deaths is obtain by interviewing a representative sample of 
respondents about the survival of all their adult sisters (to determine the number of ever-married 
sisters, how many are alive, how many are dead, and how many died during pregnancy, delivery, or 
within six weeks of pregnancy). This method is considered as not suitable for use in settings where 
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 MMR is the number of maternal deaths in a population during a given time divided by the number of live births 
during the same period (per 100.000); MMRate is the number of maternal deaths during a given time in a 
population divided by the number of women of reproductive age during the same period (per 100.000).  
The Adult lifetime risk of maternal mortality = (T15 – T50)/ l15 x MMRate, where l15, T15 and T50 are quantities 
from a life table for the female population during the period in question ( l15 equals the probability of survival 
from birth until age 15, and (T15 – T50)/l15 equals the average number of years lived between ages 15 and 50 – 
up to a maximum of 35 years – among survivors to age 15) (WHO, 2007). 
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fertility level is low or where social dislocation is high due to substantial migration. A third method is 
the verbal autopsy which consists to lead interview with the relatives of the deceased in order to assign 
the cause of the death. This method is also non exempt of bias as the accuracy of the estimates 
depends on the extent of family members’ knowledge of the events leading to the death and the skill of 
the interviewers. National population censuses also try to determine in some developing countries, 
maternal deaths. Stanton et al. (2002) evaluated the use of national census deaths data for assessing 
maternal mortality. Their conclusion based on data analysis from five national population censuses is 
that “under favourable conditions a national census is a feasible and promising approach for the 
measurement of maternal mortality”. But, this use may need a careful evaluation of the data and 
adjustment. 
In conclusion, it remains difficult to measure accurately the levels of maternal mortality. Hill, 
AbouZahr and Wardlaw (2001), tried to compare the maternal mortality on 188 countries, using a 
variety of adjustment procedures depending of the nature of the date used. Results give so wide 
uncertainty bounds that the authors estimated that comparisons between countries should be made 
with caution, and no valid conclusions can be drawn about trends over a period of time. 
Now, maternal mortality is a good indicator of the performance of health care systems. And, 
several researchers recommend to use process indicators, such as the percentage of births assisted by a 
skilled health care worker and rates of caesarean delivery for comparing reproductive health between 
countries or across time periods and monitoring purposes (Hill, AbouZahr and Wardlaw, 2001; Prual 
et al. 2000).   
Child mortality  
For similar reasons of that for maternal mortality (lack of good registration systems), it is 
difficult to measure accurately child mortality (see Table 1 and the different estimations depending of 
data sources and then methods used for estimating child mortality). Several indicators are available 
and concern specified age between birth and five years. They may be estimated for both female and 
male. These are among others: 
i) Neonatal mortality rate that is the number of deaths during the first 28 completed days of life 
per 1000 live births; 
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ii) Infant mortality that is the number of children who die before one year of age in a given year 
divided by the number of live births in the same year; 
iii) Under-five mortality that is the probability of a child born in a specific year or period dying 
before reaching the age of five, if subject to age-specific mortality rates of that period, 
(http://www.who.int/whosis/indicators/compendium/2008/3mr5/en/). 
Child mortality suffers from under registration and needs the use of several methods in order to 
measure more accurately its real level. Despite the use of improved methods, significant differences in 
its measure remain according to the sources of the data (Table 1). Demographers consider that the 
analysis of child mortality trends allows to monitoring the health transition process over countries. 
Garenne and Gakusi (2006), using 66 Demographic and Health Surveys (DHS) from 32 countries, 
might calculate death rates by yearly period and tested changes in trends using a linear logistic model8. 
They then might identify countries that entered into health transition and those that did not. For 
economists, child mortality, and more specifically infant and under-five mortality, are considered, like 
life expectancy, as a good indicator of the economic development, and then is highly correlated with 
his level.  
 
Table 1: Under-five mortality in some (arbitrary chosen) African countries from two different sources 
 
Mortality indicator Under-five mortality (per 1000) 
year 2000      2003                  2004 2006 2000         2006 
Source  
Country  
WHO 
H            F 
WHO 
H              F             H&F 
UNICEF 
H&F 
UNICEF’s MICS  
H&F 
Bénin 162       151 166        158             152 148 140            126 
Cameroun 149       140 162        158             149 149 151            148 
Ghana 112         98 106          99             112 120 111            114 
Kenya 107         98 119        113             120 121 117            121 
Source: WHO (2002, 2006),  MICS = Multiple Indicator research Cluster Surveys 
UNICEF: http://www.unicef.org/statistics/index_24302.html; http://www.unicef.org/infobycountry/index.html 
 
 
Cause-specific mortality and morbidity 
Improving population health status by reducing mortality and morbidity induces to study the 
causes of mortality and morbidity. Whatever target populations (under-five children, pregnant women, 
15-49 years age people, high-risks population, etc) it is difficult to determine accurately the causes of 
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 Logit [q(5)] = a + b x year. They found that in a smooth health transition, the slope (b) tends to be constant over 
long periods of time. 
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deaths or illness in developing countries. Once again, the limited or no functioning vital registration 
system, but also the lack of adequately trained and qualified personnel and appropriate equipment in 
developing countries do not allow to setting adequate diagnostics (Gouws et al. 2005).  
The sources of health data are numerous. Among them, we find vital registration systems, sample 
registration systems, administrative data, health facilities data, nationally representative household 
surveys (DHS and MCIS), sentinel demographic surveillance sites (DSS), epidemiological studies. We 
saw that some of them do not allow to measure accurately age-specific or cause-specific health status. 
International organizations are conscious of the low quality of health statistics in developing countries. 
Great efforts are made since several years in order to help improving this quality. They then decided to 
work together by confronting the sources of data, inducing researchers to improve the measurement 
methods. For example, estimates of HIV prevalence have been developed by UNAIDS and WHO for 
most Member States and revised periodically to account for new data and improved methods9 (WHO 
health report, statistical annex). 
Demographers, epidemiologists and public health researchers complain that the lack of adequate data: 
- obstructs the process of planning and evaluation of interventions to control diseases,  
- does not allow policy-makers to generate cost-effective interventions. 
They then proposed several alternative approaches to copying with inadequate data. After a 
systematic and comprehensive literature review of all studies published since 1980 reporting under-5 
diarrhoea mortality, Boschi-Pinto et al. (2008) estimated a logit model to relate studies and population 
characteristics to proportional mortality from diarrhoea and to predict its distribution in national 
populations10. Becker et al. (2006) try to propose an effective ranking list of the leading causes of 
death using Taucher’s criteria causal categories, and grouping diseases upon measures that could 
prevented them, such as prevention by vaccination (measles, tetanus) or avoidable by early diagnosis 
and adequate treatment (tuberculosis, malaria). And they proposed, like Hill, Abou-Zahr and Wardlaw 
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 Two different types of models are used, depending on the nature of the epidemic in countries. 
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 Logit (% diarrhoea deaths) = 5.31 + 2.38(ln5q0) + 2.01(time) + 8.56 (region). 
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(2001), Abou-Zarh and Wardlaw (2001), to use process indicators11 for comparing health between 
countries or across time periods and for monitoring and evaluation purposes.  
As in the case of maternal mortality, the method of verbal autopsy (VA) is used in order to 
determine cause-specific mortality and largely discussed in the literature. Using this approach, 
Fantahun et al. (2006) estimated a probabilistic model for interpreting community-based VA interview 
in order to investigate patterns of cause-specific mortality in rural Ethiopia. They found that the model 
fit well for determining cause-specific mortality12 and was less labour-intensive than interpretation by 
physicians. But, VA is not always considered as an effective method. In the case of malaria, this 
approach has low sensitivity and low specificity (Boerma et al., 200; le Hesran, 2000).  
Nutritional indicators 
The measurement of the nutritional status into a population is an important stake for several 
reasons. First, malnutrition seems to be a main cause of child mortality in developing countries. It is 
associated with about 50% of all deaths among children as it constitutes a risk factor of death 
associated with specific diseases. Association has been found with diarrhoea and acute respiratory 
infection (Rice et al., 2002). As mentioned by Rice et al. (2002), this association has important 
implications for the evaluation of nutritional intervention programmes as the programs effectiveness 
may vary with different disease profiles. Second, adult malnutrition is also a cause of mortality and 
morbidity. Overweight and obesity are at increased risk of adverse metabolic outcomes and 
subsequently, increase the risk of diseases, such as coronary heart disease, diabetes or cancer. Third, 
malnutrition during childhood will have negative consequence on future gains. Four, malnutrition is a 
risk factor of maternal mortality, associated with malaria and HIV/AIDS.  
Several nutritional indicators are available. The most common used for economic research are, as 
they are easy to obtain, anthropometric measures that allow to assessing malnutrition status by relating 
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 Process indicators are the advantages to be better measured and highly correlated with the cause or the 
consequence of the disease. We find in this category, indicators associated: 
- with maternal mortality, such as percentage of births assisted by a skilled health care worker and rates 
of caesarean delivery 
- with child mortality and morbidity, such as percentage of child completely vaccinated, the number of 
child sleeping under insecticide bed nets.  
12
 Among causes of deaths, kwashiorkor, blood diarrhoea, diarrhoea, malaria, TB, HIV, were claimed.  
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body measurements (weight and height/lenght) to an individual’s age or height. Three indicators, 
stunting, wasting, and being underweight, are available for assessing child nutritional status.  
Stunting indicates chronic under-nutrition. It is measured by the height-for-age that express past 
retardation growth. Wasting indicates acute under-nutrition. It is measured by the weight for height 
indices that concern current malnutrition. Underweight children may either be chronically or acutely 
malnourished or a combination of both. It is measured by the weight-for-age. Anthropometric values 
are compared across individuals using a standardized age- and sex-specific growth reference (the 
National Center for Health Statistics and WHO (NCHS/WHO) international reference since 197013). 
Z-scores are calculated for each anthropometric value14. The Z-score system expresses anthropometric 
values as several standard deviations (SDs) below or above the reference mean or median value: 
 
Z-score = anthropometric value of the studied population – Median value of the reference population  
     Standard deviation of the reference population  
 
Growth retardation prevalence may then be calculated per age, sex, region, and country. The 
prevalence of each type of malnutrition is the proportion of weight-for-age, height-for-age and weight-
for-height below -2 and -3 standard deviations (SDs). 
As for under-nutrition, over-nutrition is a health problem. Overweight and obesity both in 
adult and child populations become to be an increasing public health problem. The WHO considers 
that this problem is affecting many low- and middle-income countries.  “In 2007, an estimated 22 
million children under the age of 5 years were overweight throughout the world. More than 75% of 
overweight and obese children live in low- and middle-income countries…. More than 1 billion 
adults are overweight and at least 300 million of them clinically obese”15. Now, childhood 
obesity is associated with a higher chance of premature death and disability in adulthood. Body Mass 
Index (BMI) was the classical tool for indicating nutritional status in adults. It was defined as the 
weight in kilograms divided by the square of the height in meter (kg/m²). This index allowed to 
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 New growth standards for infants and children up to the age of 5 years were developed in 2006 by the World 
Health Organization. www.who.int/chilgrowth/en. 
14
 They are: height-for-age Z-scores (HAZ), weight-for-age Z-scores (WAZ), weight-for-height Z-scores (WHZ). 
15
 http://www.who.int/dietphysicalactivity/childhood/en/ 
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classifying overweight and obesity (Table 2). It was now currently used for school age children and 
adolescents, and is recommended for use with children under-five years old (WHO, website).  
  Using BMI classification, the prevalence of overweight and obesity among adults (percentage 
of 15 years and older population with a BMI ≥ 30.0 kg/m²), adolescents and children may be 
calculated.   
 
Table 2: BMI classification for adults  
  
Definition  BMI 
Underweight < 18.5 
Normal range 18.5 – 24.9 
Overweight ≥ 25 
Pre-obese 25 – 29.9 
Obese ≥ 30.0 
Source: http://www.who.int/dietphysicalactivity/childhood_what/en/index.html 
 
 
Conclusion concerning the single measures of health status 
i) If mortality indicators remain essential, due to poor registration system, they suffer from bias 
in measurement. This bias is yet higher when cause-specific mortality or morbidity are 
considered, those indicators should be used, but results may be interpreted with caution and 
need to be largely discussed. 
ii) These measures have the disadvantage to take into consideration one dimension of health. For 
that consideration, they could no be used as a representative measure of global health status; 
iii) Cause-specific morbidity rates, measured by prevalence and incidence rates of specific 
disease, are inaccurately measures of the severity of the disease and then the real consequence 
of the disease on the population well-being and quality of life. 
 
b) Summary measures  
Summary measures have been developed in order to mitigate the partial measurement of both 
mortality and morbidity health indicators, by capturing both fatal and non-fatal health outcomes. The 
objective of those measures is to give an indication of the burden of disease. Two indicators have been 
proposed: the healthy life expectancy at birth (HALE) and the disability-adjusted life year (DALY). 
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Healthy life expectancy (HALE) at birth  
  The high increase of life expectancy at birth and the great interest into the quality of life in 
developed countries, allowed demographers to introducing the notion of full health in the life 
expectancy indicator. A new indicator, the HALE, was then proposed. It is expressed as the “average 
number of years that a person can expect to live in "full health" by taking into account years lived in 
less than full health due to disease and/or injury”. It adds up expectation of life for different health 
states, adjusted for severity distribution making it sensitive to changes over time or differences 
between countries in the severity distribution of health states. 
(http://www.who.int/whosis/indicators/2007HALE0/en/). This indicator was calculated per country, 
and sex, but only in 2002 (WHO, 2002, World health report, 2002).  
The correlation between LE and HALE is very strong, and if this last indicator is interesting for 
monitoring the quality degradation of the length of life in developed countries, and also in developing 
countries, it does not bring better advantages or information by using this indicator for international 
comparisons in studies determining economic effect of poor health.  
 
Table 2: Life expectancy (LE) and healthy life expectancy (HALE) at birth in some WHO members 
state, estimates for 2002 (both sexes) 
 
Member state 
 
LE 
(years) 
HALE 
(years) 
Difference 
(years) 
Member state LE 
(years) 
HALE 
(years) 
Difference 
(years) 
Argentine  74.4 65.3 9.1 Indonesia 66.4 58.1 8.3 
Belgium 78.4 71.1 7.3 Kenya 50.9 44.4 6.5 
Bolivia 63.2 54.4 8.8 Mauritania  52.1 44.5 7.6 
Burkina Faso 41.7 35.6 6.1 Namibia 49.3 43.3 6 
China  71.1 63.1 8.0 Niger 42.6 35.5 7 
Denmark 77.2 69.8 7.4 Nigeria 48.8 41.5 7.3 
Egypt 67.1 59 8.1 Philippines 68.3 59.3 9 
Ethiopia 48 41.2 6.8 Russia  64.6 58.4 6.2 
France 79.8 69.3 10.5 Sierra Leone 34 28.6 5.4 
Germany 78.7 71.8 6.9 U S A 77.3 69.3 8 
Ghana 57.6 49.8 7.8 Viet Nam 69.6 61.3 8.3 
Source: WHO (2004), statistical annex 
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Disability Adjusted Life Year16 
In 1993, the World Bank and WHO proposed a new health measure that would give an indication 
of the burden of disease, the disability-adjusted life year (DALY). The DALY can be thought of one 
lost year of healthy life, due to disease or injury. The first statistics upon DALYS were published in 
the 1993 World Bank annual report. The purpose of this indicator has been to take into consideration 
three dimensions of health: mortality, disability and incapacity through the severity of the disease.  
DALYs are calculated as the sum of years life lost due to premature mortality (YLL) in the 
population and years of life lost due to disability (YLD) for incident cases of the disease or injury (i.e. 
years lived with disability, WHO, 2004, statistical annex; ).  
DALY
 
 = YLL
 
 + YLD
   
 
where: 
YLL = N x L  
YLL corresponds to the number of deaths (N) multiplied by the standard life expectancy at the age at 
which death occurs (L); 
 
YLD = I x DW x L  
YLD corresponds to the number of disability (incident) cases (I) multiplied by the average duration of 
the disease (L, in years) multiplied by a weight factor that reflects the severity of the disease (DW, 
disability weight) on a scale from 0 (perfect health) to 1 (death)17. Disability weights reflect societal 
preferences for difference health states in the relation to the societal ideal of good health. Disability 
refers to departures from ideal health in important domains of health: mobility, self-care, participation 
in usual activities, pain and discomfort, anxiety and depression, cognitive impairment (WHO, 2004, 
chapter 3). The approach for measuring preference for defined health states has changed since the 
beginning18. The new approach used a standard health states description based on eight core domains 
of health (mobility, self care, pain and discomfort, cognition, vision, interpersonal activities, sleep and 
                                                 
16
 A large part of this section is based on the GBD, update (WHO, 2004). 
17
 This assignment is inverted compared to that used for the QALY, where 0 is death and 1, perfect health. But, 
while QALY measures equivalent healthy years lived, DALY measures loss of health (GBD, 2004).  
18
 Small groups of participants (medical and public health experts) were asked for making a judgement about the 
severity of the condition and the preference for time spent in each severity level. 
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energy, affect). In 2003, disability weights are revised and based on health state valuations from large 
representative population samples in over 70 countries.   
The DALY indicator measures the differences between a current situation and an ideal 
situation where everyone lives up to the age of the standard health expectancy, and in perfect health. 
The standard life expectancy at birth is set at 80 years for men and 82.5 for women (GBD, 2004). The 
time social preference (people preferring a healthy year of life now rather than in the future) and the 
age social preference (people valuing more highly a year lived by a young adult than a year lived by 
young child or older person) were taken into consideration. Calculations of YLL and YLD use a 3% 
time discounting and non-uniform age weights that give less weight to years lived at young and older 
ages (WHO,2004, statistical annex; Jamison et al, 2006).  
DALYs were calculated for about one hundred causes or diseases, including maternal, 
perinatal and nutritional conditions, and injuries, both intentional and unintentional. They also are 
calculated for risk factors.  Risk factors are factors that cause diseases. Among them, they are 
underweight, overweight, unsafe sex, blood pressure, tobacco, unsafe water, sanitation and hygiene, 
indoor smoke from solid fuels (WHO, 2002; Lopez et al, 2006). DALYs were calculated per sex, and 
mortality stratum in WHO regions (Africa, the Americas, Eastern Mediterranean, Europe, South-East 
Asia, and Western Pacific). Data were available for 1999, 2000, 2001 and 2002 (WHO 2000 to 2003).  
DALYs per WHO member state were calculated only for one year, in 2002 (World Health Report, 
2004).  
Since 2002, partial updates of GBD ranking have been published. Now, the Institute of health 
metrics (http://www.healthmetricsandevaluation.org) estimated that disease burden measure contains 
some outdated and inconsistent information. Researchers of this institute observed that substantial data 
gaps and deficiencies remain, particularly for regions with limited death registration data. They 
underlined the need of “reassess in a newly comprehensive study”. They work in that direction, and 
undertook to update projections to the year 2030, using the updated GBD 2004 results as a starting-
point (http://www.healthmetricsandevaluation.org/who/director.html).  
For summarizing, DALY, as a summary measure, has the advantage to take into consideration 
either the two dimensions of health outcome (mortality and disability), as disease severity and social 
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preferences for health states valuation. This indicator serves to measure health differences in the 
world, and then to improve health status and healthy expectancy life. It has at least four objectives 
(GBD, 2004): 
i) To provide a summary measure of health status and then contribute to determining health 
priorities; 
ii) To contribute to identify the most unhealthy population group and then to target health 
intervention; 
iii) To provide a comparable health measure for assessing the effect of health interventions; 
iv) To help country governments to more rapidly reach the MDGs. 
 
Although, the Quality-Adjusted Life Year (QALY) is a well-known health indicator, we choose to just 
introduce it here for two reasons. The concept of QALY was initially introduced in 1968 by Dr. H. 
Karman’s team after having observed that the quality of life of their patients was highly different 
depending on the treatment they received for the same disease (Goerdt et al. 1996). This indicator may 
be more appropriate for improving the quality of healthcare than for establishing health priorities (as 
also questioned by Jourdain, 1993, and Williams, 1996). Beyond the debate on the concept of utility 
upon which this indicator is based, the concept of quality of life is not a concrete concept for 
population from developing countries while the notion of rescue in health is highly present.     
The formula for calculating QALY (Q), is: 
 Q = S x W  
Where: 
 S, is the number of life years saved thank to the treatment 
 W V xP Ni i
i
=∑ ( ) /    
With Vi, the value or social preference for the health status i, Pi, the number of persons being in the 
health status i, N the total number of persons concerned by all described health status, from perfect 
health to death. 
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Adults’ health status 
Self-reported illness symptoms and limitations in the physical ability to perform activities of daily 
living (ADL) were two health measures used to study adults’ health status. Initially, ADL’s measure 
was developed for studying disability levels among the elderly. Referred as the Katz ADL, this index 
was developed in order to detect elderly’ problems in performing activities of daily living (Katz et al. 
1963). Six functions were defined and concerned bathing, dressing, toileting, transferring, continence, 
and feeding. They were scored yes (=1) or no (=0) for independence. A score of 6 indicated full 
function, 4, moderate impairment, and 2 or less, severe functional impairment.  
While self-reported illness symptoms are suspected to be correlated with income and education, 
ADL measure is bias-exempt and considered as reliable and valid measures, whatever the local culture 
context (Reijneveld, Spijker and Dijkshoorn, 2007; Gertler and Gruber, 2002; Strauss et al. 1993). 
Questionnaires for capturing ADLs may be more or less short19. ALDs are divided into basic and 
intermediate activities. Basic ADLs concern the ability to perform the six initial functions (to bathe, 
feed, clothe yourself, etc.). Intermediate ADLs concern for example, ability to carry a heavy load for 
20 meters or take water from a well (Gertler and Gruber, 2002). ADLs may be found in some national 
household surveys. They also may be collected in specific surveys, as it is easy to collect information 
on its components. This measure has been used in studies of the relationships between health and 
labour market outcomes (Strauss and Thomas, 1996) and of assessing the health change over time 
(Gertler and Gruber, 2002). Finally, the ADL questionnaire could be short and simple, but also valid 
as the EuroQol questionnaire (EQ-5D) is (see the discussion around the advantages of a non 
complicated instrument in Dorman et al., 1997).  
 
III – Implication for economic research 
Facing to more than thousand health indicators, economists have to choose which health 
indicator fits well for their studies. The use of that health indicator, instead of another one, is upon the 
objective of the undertaken economic study. The first question is which kind of economic research is 
                                                 
19
 The EuroQol questionnaire (EQ-5D) included five questions whose three are summary physical abilities 
(walk, bathe & clothe, current activities). 
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done when economists work in the health field? The main goal of economic research in health is to 
contribute to the fight against poverty through health improvement. For that, at least five targets may 
be followed by economists: 
i) The first is to assess the direct and indirect economic costs of health. Studies on direct cost 
induce to find the means to decrease that cost by improving the efficiency and effectiveness of 
health system, and preventing illness occurrence. But they also allow to identify the economic 
and social determinants of healthcare demand and to measure the inequity level in health 
access. Studies on indirect cost induce to assess the effect of health on the development or 
household economic status; 
ii) The second is to identify the different sources of health financing for, as resources are 
insufficient, improving the supply of financing, but also the efficiency of both public and 
private health expenditures;  
iii) The third is to identify the best cost-effectiveness health interventions for helping policy-
makers to prioritize public health interventions;  
iv) The fourth is to assess the effect of economic interventions on health;  
v) The fifth is to identify the economic and social determinants of health. 
 
When economists provide information on the cost of healthcare, whether cost is supported by 
states or by households, they want to know how much time states could finance this cost (this question 
is a crude question in the case of HIV/AIDS) or whether healthcare cost will bring people to poverty 
due to catastrophic payments. It is well-known that the frequentation of health facilities in Africa is 
very low (the number of contacts per person per year is between 0.2 and 0.5; Audibert et al, 2005). 
The question asked by policy-makers is why people do not use health facilities. Is the barrier to 
healthcare, an economic, social or cultural problem? Economists may answer to that question by using 
healthcare demand models. That study needs to undertake household surveys in which people are 
questioned about the occurrence of health problems during the four weeks preceding the survey (as in 
DHS surveys for example) and the access to healthcare. The health status is not really defined as 
people describe symptoms because they are often unable to identify the cause of illness. However, it 
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would be easy to add a question on global health and to ask people to determine their health status 
using a graduate scale (see the EuroQol questionnaire, EQ-5D version). Although, we know that the 
poor report less illness episodes than the rich, the analysis of this kind of surveys and the data they 
provided, is useful for assessing direct health cost. 
The indirect cost of health is the cost induced by productivity and work days lost. In this 
perspective, one considers that poor health is a cause of poor household economic status or low 
development. Economists working on this topic are faced to a huge problem of health measure. When, 
they want to assess the effect of poor health at the macro-economic level, they have to choose an 
indicator that measure overall health status. As a summary indicator, the DALY should be used as a 
measure of overall health status as it includes more than hundred causes of disability or deaths. But 
this indicator is, calculated per WHO region and not per country, except from 2002.  
Economists use then health indicators supposed to be indirect measures of overall health status as 
life expectancy at birth and child mortality. The measure of child mortality (as maternal mortality) was 
traditionally done by demographers and epidemiologists. We saw the difficulty they encountered, due 
to biases in data records, to provide accurate measures of mortality in general and maternal and child 
mortality in particular. Now, maternal and child mortality are largely used into the perspective of the 
health MDGs for providing information concerning progress towards achieving the MDG4 and MDG5 
targets, and the performance of health systems. Demographic and Health Surveys (DHS), using a 
direct sisterhood approach and verbal autopsy, provide data on maternal and child mortality. Acute 
discussion rose around biases from DHS mortality data in order to assess the quality of the data 
collected and discuss the appropriate use of these data (Stanton, Abderrahim, Hill, 2000; Garenne and 
Gakusi, 2006). Economists have little to do in that debate: their contribution into health metric will be 
highest by interpreting the results of their economic research in health, keeping in mind that the 
measure of health is not free from bias.  
Economists may have other useful health indicators, such as anthropometric measures (height and 
weight) both for child and adult. They are rapid and inexpensive to obtain, and easy to use. Data could 
also be found in a number of data sources such as nationally representative household surveys, 
including DHS, and WHO Global database. Anthropometric measures will serve for assessing the 
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economic effect of poor past health. Relationships between past malnutrition and adult gains have 
been set20. They also serve for other field research. The WHO Global database allows scientists in 
economic research to undertake international comparison of nutritional status, evaluating nutritional 
and other public health interventions, monitoring trends in child growth. 
However, such as public health researchers, economists may need to obtain adequate measure of 
health indicators per cause-specific mortality and morbidity. Economists will have to use cause-
specific mortality and morbidity indicators with caution. In order to cope with bias measurement of 
these indicators, some researchers proposed to use process indicators as indirect measures of health 
status. Process indicators are easy to collect, best measured and highly correlated with the cause or the 
consequence of diseases. Then, they could be used for comparing health between countries or across 
time periods, and for monitoring and evaluation purposes (Hill, Abou-Zahr, Wardlaw, 2001; Abou-
Zarh et Wardlaw, 2001; Becker et al., 2006). In other hand, even if all countries did not enter their 
epidemiological transition, non-communicable diseases become more important and may cause 
economic losses. Non-communicable diseases currently represent 43% of the global burden of disease 
and are expected to account for 60% of the disease burden and 73% of all deaths in the world by 2020 
(Sarrafzadegan et al. 2009). Chronic diseases will be no exceptional in developing countries (Malone 
et al. 1999). Communicable diseases are projected to account for 20% of total DALYs lost in 2030, 
compared with just fewer than 40% in 2004. The non communicable disease burden is projected to 
increase to 66% in 2030, and to represent a greater burden of disease than communicable diseases in 
all income groups, including low-income countries21. Due to lack of data, studies on the economic 
effect of non communicable diseases may not be undertaken. Economists may add their voice when 
public health researchers and epidemiologists ask for including in household surveys target disease 
(Murray and Frenk, 2008; Sarrafzadegan, 2009). At the last, when economists want to assess the 
economic effect of a specific disease at microeconomic level, they are faced with a problem of 
obtaining health indicator that accurately measures the severity of the disease. Economists may ask 
                                                 
20
 For example, a delay in childhood development (height), or low weight at birth would have an impact on 
future wages or labour productivity (Strauss and Thomas, 1998; Huffman and Orazem, Berham, 1999; Behrman 
and Rosenzweig 2004). 
21
 http://www.healthmetricsandevaluation.org/who/director.html. 
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epidemiologists for providing indicators in closer relation with health economic research. A narrow 
collaboration between epidemiologists and economists may allow to improving health measurement 
for both evaluating health interventions and assessing economic effects of health. That could be done 
with more multidisciplinary studies.  
If health may be to have negative effect on economic status, the reverse is true: economic status 
(such as level as economic inequality) may determine health status. Then, studies of health economic 
and social determinants could help to orient health interventions, but also economic programs forward 
the poor. For example, Banerjee, Deaton and Duflo (2004) studied the relationship between health, 
happiness and economic status. They used several health indicators: self-reported health, BMI, the 
haemoglobin count and blood pressure. They showed that individuals in the lower third of the per capita 
income distribution have, on average, a lower level of self-reported health, lower BMI, and tare more likely 
to have a haemoglobin count below 12 than those in the upper third.  
The DHS surveys in providing population-based estimates of the current health of women, men 
and children, and also demographic, social and economic characteristics of individuals and households 
allow to identifying the role of economic status on health in numerous developing countries. For 
example, Lachaud (2007) used the Burkina Faso DHS data and found a positive relationship between 
HIV prevalence in adult women and men and living standards of individuals.  
    
IV – Conclusion 
If, due to the multi-dimensional characteristic of health, and the lack of adequate registration 
system, the measure of health is difficult, researchers are faced to a lot of health indicators. In one 
sense, that abundance, nourished by a great availability of health statistics databases, would serve 
health economic research. Databases are provided by international organisations such as WHO, 
UNDP, UNICEF, the World Bank, UNAIDS, USAID and UNFPA. The WHO, for example, provides 
health statistics into her WHOSIS database (http://www.who.int/whosis/fr/). USAID, in financing 
DHS surveys in number of developing countries, allowed to providing a lot of both direct and indirect 
health indicators.  
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As an indicator of the disease burden, the DALY will be an interesting indicator for 
international studies concerning: 
- The relation between health and development, using the total number of DALYs. 
- The role of communicable and non-communicable diseases on poverty, using DALYs per cause. 
- The role of specific diseases, such as chronic non-communicable disease or endemic 
communicable disease on poverty, using DALYs per specific disease. 
We propose some recommendations that are: 
- to encourage economic researchers to more use existing international and national databases, such as 
the WHOSIS and MCIS databases that have not been fully exploited, and DHS; 
- to exploit the resources providing by the DALYs indicators, either by cause or by risk factor. As 
burden disease indicators, they measured health status in a more comprehensive means that only 
mortality or morbidity rates. The DALYs per cause and risk factor may be more used in the economic 
research in order to assess the economic role of health. Although, this indicator is calculated per WHO 
region, the proposed decomposition per mortality stratum gives the opportunity to use this indicator at 
macroeconomic research and to wait for a new update revision of DALYs per country;  
- to systematically collect anthropometric measures and ALDs measures while economists undertake 
household surveys, as they are easy and low expensive to collect;  
- to develop narrow collaboration between epidemiologists and economists in order to improve results 
both in health economic research and health public research. 
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